+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mometasone"

Anti-Asthmatics and COPD Drugs Market Report 2025 - Product Thumbnail Image

Anti-Asthmatics and COPD Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Asthma Drugs Market Report 2025 - Product Thumbnail Image

Asthma Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Bronchodilators Market Report 2025 - Product Thumbnail Image

Bronchodilators Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Sinusitis Pipeline Insight Analysis Report - Product Thumbnail Image

Sinusitis Pipeline Insight Analysis Report

  • Drug Pipelines
  • August 2024
  • 150 Pages
  • Global
From
Asthma - Competitive landscape, 2023 - Product Thumbnail Image

Asthma - Competitive landscape, 2023

  • Report
  • April 2023
  • 240 Pages
  • Global
From
From
From
Sinusitis - Pipeline Insight, 2024 - Product Thumbnail Image

Sinusitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
From
COPD in the United States: Understanding the COPD Patient Experience - Product Thumbnail Image

COPD in the United States: Understanding the COPD Patient Experience

  • Report
  • January 2024
  • 156 Pages
  • United States
  • 14 Results (Page 1 of 1)
Loading Indicator

Mometasone is a corticosteroid drug used to treat respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). It is available in both topical and inhaled forms, and is used to reduce inflammation in the airways. It is often prescribed in combination with other drugs, such as bronchodilators, to provide more comprehensive relief. Mometasone is generally well-tolerated, but can cause side effects such as headaches, nausea, and throat irritation. The mometasone market is a subset of the larger respiratory drugs market, which includes a variety of treatments for respiratory conditions. The market is highly competitive, with a number of major pharmaceutical companies offering mometasone-based products. These include GlaxoSmithKline, Merck, Novartis, and Pfizer. Generic versions of mometasone are also available, providing an affordable alternative for patients. Show Less Read more